Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a nn » a non (Expand Search), a n (Expand Search), _ nn (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a nn » a non (Expand Search), a n (Expand Search), _ nn (Expand Search)
-
15821
-
15822
DdataSheet_1_Normal T and B Cell Responses Against SARS-CoV-2 in a Family With a Non-Functional Vitamin D Receptor: A Case Report.pdf
Published 2021“…Any measures to slow down the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to decrease disease severity are highly requested. …”
-
15823
-
15824
Low efficiency induction of neural rosette-like cells from the hESCs CHA13 and CHA15 using a previously published stromal cell co-culture method.
Published 2015“…(B-E) Morphology of H9 (B), HSF6 (C), CAH13 (D), and CHA15 (E) cells under neural induction (stage I) conditions (on γ-irradiated MS5 feeder layer in ITS+AA medium). H9 and HSF6 cells formed neural rosette structures with a neuroepithelial cell morphology (arrows in B and C). …”
-
15825
-
15826
-
15827
-
15828
-
15829
-
15830
-
15831
-
15832
Treatment with APB5, but not APA5 attenuates pulmonary fibrosis in BLM-treated mice.
Published 2018“…<p>BLM was injected subcutaneously with a mini-osmotic pump for 7 days. APA5, APB5, and IgG as a control were injected intraperitoneally every other day from the start on Day 0 to sacrifice on Day 28. …”
-
15833
Effects of adenosine receptor-specific antagonists on responses to hypoxia at E9.5 and E12.5.
Published 2013“…<p>A and B: Specimens were treated with DPCPX, an A1AR-specific antagonist at 10 nM (A: E9.5, n = 15; B: E12.5, n = 23), SCH-58261, an A2aAR-specific antagonist at 100 nM (A: E9.5, n = 15; B: E12.5, n = 19), or vehicle (A: E9.5, n = 27; B: E12.5, n = 42) at 15 min (arrows), and exposed to hypoxia (gray boxes). …”
-
15834
-
15835
-
15836
-
15837
-
15838
-
15839
-
15840